Evidence map›Paper›PMID 27131348›Full record

ArticleHuman molecular genetics2016

Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects.

Fengping Dong, Joanna Jiang, Colleen McSweeney, Donghua Zou, Long Liu, Yingwei Mao

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A NovelClinical case reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. CTNNB1 syndrome mouse models.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Circadian clock crosstalks with autism.Brain and behavior · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Critical periods and Autism Spectrum Disorders, a role for sleep.Neurobiology of sleep and circadian rhythms · 2023
    Article
  20. CTNNB1 in neurodevelopmental disorders.Frontiers in psychiatry · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Fengping DongDepartment of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Joanna JiangDepartment of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Colleen McSweeneyDepartment of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Donghua ZouDepartment of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Long LiuDepartment of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Yingwei MaoDepartment of Biology, Pennsylvania State University, University Park, PA 16802, USA yzm1@psu.edu.
Pennsylvania State University · USFirst Affiliated Hospital of GuangXi Medical University · CNNational University of Defense Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in β-catenin (CTNNB1) have been implicated in cancer and mental disorders. Recently, loss-of-function mutations of CTNNB1 were linked to intellectual disability (ID), and rare mutations were identified in patients with autism spectrum disorder (ASD). As a key regulator of the canonical Wnt pathway, CTNNB1 plays an essential role in neurodevelopment. However, the function of CTNNB1 in specific neuronal subtypes is unclear. To understand how CTNNB1 deficiency contributes to ASD, we generated CTNNB1 conditional knockout (cKO) mice in parvalbumin interneurons. The cKO mice had increased anxiety, but had no overall change in motor function. Interestingly, CTNNB1 cKO in PV-interneurons significantly impaired object recognition and social interactions and elevated repetitive behaviors, which mimic the core symptoms of patients with ASD. Surprisingly, deleting CTNNB1 in parvalbumin-interneurons enhanced spatial memory. To determine the effect of CTNNB1 KO in overall neuronal activity, we found that c-Fos was significantly reduced in the cortex, but not in the dentate gyrus and the amygdala. Our findings revealed a cell type-specific role of CTNNB1 gene in regulation of cognitive and autistic-like behaviors. Thus, this study has important implications for development of therapies for ASDs carrying the CTNNB1 mutation or other ASDs that are associated with mutations in the Wnt pathway. In addition, our study contributes to a broader understanding of the regulation of the inhibitory circuitry.

Indexed as

AnimalsAutism Spectrum DisorderAutistic Disorderbeta CateninInterneuronsMiceMice, KnockoutParvalbuminsSequence DeletionWnt Signaling Pathwaybeta CateninCTNNB1 protein, mouseParvalbumins

Identifiers

PMID27131348
PMCPMC5181638
OpenAlexW2344860861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.